ECSP993062A - NEW PEPTIDES TO BE USED IN AN INDUCED TOLERANCE THERAPY TO PREVENT AUTOIMMUNE ALTERATIONS, IN PARTICULAR, RHEUMATOID ARTHRITIS - Google Patents

NEW PEPTIDES TO BE USED IN AN INDUCED TOLERANCE THERAPY TO PREVENT AUTOIMMUNE ALTERATIONS, IN PARTICULAR, RHEUMATOID ARTHRITIS

Info

Publication number
ECSP993062A
ECSP993062A ECSP993062A ECSP993062A EC SP993062 A ECSP993062 A EC SP993062A EC SP993062 A ECSP993062 A EC SP993062A EC SP993062 A ECSP993062 A EC SP993062A
Authority
EC
Ecuador
Prior art keywords
alterations
rheumatoid arthritis
induced tolerance
new peptides
tolerance therapy
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Gijsbertus Francisc Verheijden
Anna Maria Helena Boots
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993062 priority Critical patent/ECSP993062A/en
Publication of ECSP993062A publication Critical patent/ECSP993062A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere al uso de nuevos péptidos de una terapia de tolerancia inducida por péptidos para impedir las alteraciones autiinmunes, y en particular, su uso en el tratamiento de la destrucción crónica del cartílago articular. La invención además incluye composiciones farmacéuticas que comprenden dichos péptidos y un método de diagnóstico para la detección de células T autocorrectivas en una muestra de prueba.The present invention relates to the use of new peptides of a peptide-induced tolerance therapy to prevent auti-immune disorders, and in particular, their use in the treatment of chronic destruction of articular cartilage. The invention further includes pharmaceutical compositions comprising said peptides and a diagnostic method for detecting self-correcting T cells in a test sample.

ECSP993062 1999-07-20 1999-07-20 NEW PEPTIDES TO BE USED IN AN INDUCED TOLERANCE THERAPY TO PREVENT AUTOIMMUNE ALTERATIONS, IN PARTICULAR, RHEUMATOID ARTHRITIS ECSP993062A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993062 ECSP993062A (en) 1999-07-20 1999-07-20 NEW PEPTIDES TO BE USED IN AN INDUCED TOLERANCE THERAPY TO PREVENT AUTOIMMUNE ALTERATIONS, IN PARTICULAR, RHEUMATOID ARTHRITIS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993062 ECSP993062A (en) 1999-07-20 1999-07-20 NEW PEPTIDES TO BE USED IN AN INDUCED TOLERANCE THERAPY TO PREVENT AUTOIMMUNE ALTERATIONS, IN PARTICULAR, RHEUMATOID ARTHRITIS

Publications (1)

Publication Number Publication Date
ECSP993062A true ECSP993062A (en) 1999-09-09

Family

ID=42044049

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993062 ECSP993062A (en) 1999-07-20 1999-07-20 NEW PEPTIDES TO BE USED IN AN INDUCED TOLERANCE THERAPY TO PREVENT AUTOIMMUNE ALTERATIONS, IN PARTICULAR, RHEUMATOID ARTHRITIS

Country Status (1)

Country Link
EC (1) ECSP993062A (en)

Similar Documents

Publication Publication Date Title
ATE416682T1 (en) DEVICE FOR REPAIRING ARTIFICIAL CARTILAGE DEFECTS
NI200700222A (en) OMEGA-SUBSTITUTED N-HYDROXIAMIDS WITH TRICICLIC GROUPS AS INHIBITORS OF HISTONE DEACETILASE, ITS PREPARATION AND ITS USE IN PHARMACEUTICAL FORMULATIONS.
AR047729A1 (en) THERAPEUTIC ANTIBODIES THAT BIND APOLIPOPROTEIN E (APOE)
BRPI0407397A (en) Mon 88913 cotton event and compositions and methods for its detection
MA31666B1 (en) Periodic anti-cxcr4 peptide
ES2549551T1 (en) Method of increasing bone hardness and stiffness and reducing fractures   
DE602006011934D1 (en) METHOD FOR DETECTING AUTOANTIC BODIES MADE IN RHEUMATOIDER ARTHRITIS
NZ332427A (en) Peptides suitable for use in antigen specific immunosuppressive therapy
BR9506377A (en) Peptide comprising a substrate of gp-39 hc protein gp-39 hc or peptides pharmaceutical composition use of gp-39 hc protein or one or more of the peptides composition of diagnosis and diagnostic process and test kit for the detection of self-diagnosed t reactive activated
AR036984A1 (en) AN ISOLATED IMMUNOMODULATOR POLYMER, A PHARMACEUTICAL COMPOSITION, AN ISOLATED IMMUNOMODULATOR POLYACARIDE, USE OF IMMUNOMODULATING POLYMERS FOR THE MANUFACTURE OF MEDICINES FOR THE SPECIFIC MODULATION OF IMMUNITY PROCESSES, A SYSTEM FOR SELECTING DESIGN
ES2174770T1 (en) PEPTIDES DESIGNED FOR DIAGNOSIS AND TREATMENT OF Rheumatoid ARTHRITIS.
BR0113213A (en) Method for diagnosing an autoimmune disease, antibody, diagnostic composition, and antibody use
ATE467124T1 (en) MOLECULES INTERACTING WITH PRP SP SC/SP AND THEIR USE
Pérez-García et al. Proteomic analysis of synovial fibroblasts and articular chondrocytes co-cultures reveals valuable vip-modulated inflammatory and degradative proteins in osteoarthritis
BRPI0516568A (en) biomaterials consisting of sulfated hyaluronic acid and gelane as well as pharmaceutical composition and use thereof
NO975968D0 (en) New peptides for use in the treatment of T-cell mediated cartilage destruction in autoimmune diseases
Kulkarni et al. Oral microbiome in pre-rheumatoid arthritis: the role of Aggregatibacter actinomycetemcomitans in bacterial composition
UY27583A1 (en) ANTIBODY INHIBITING THE ACTIVITY OF THE PRECURSOR CELL FACTOR AND ITS USE FOR THE TREATMENT OF ASTHMA
ECSP993062A (en) NEW PEPTIDES TO BE USED IN AN INDUCED TOLERANCE THERAPY TO PREVENT AUTOIMMUNE ALTERATIONS, IN PARTICULAR, RHEUMATOID ARTHRITIS
IL165364A (en) Method for identifying peptides which mimic an idiotype of an autoimmune disease-associated auto-antibody and peptides identified by such method and their use
Tobon et al. Anti-cyclic citrullinated peptide antibodies in patients with primary Sjögren’s syndrome
AR027694A1 (en) USE OF MY PROTEIN FOR THE TREATMENT OF AUTOIMMUNE DISEASES
TR200100175T2 (en) New peptides for use in immunotherapy of autoimmune diseases.
EA200001127A1 (en) BACTERIAL FEROMONS AND THEIR USE
BRPI0515893B8 (en) human heat stress protein peptides, pharmaceutical composition, and, use of the peptide and pharmaceutical composition.